Article
A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC).
Science advances - 23 Jan 2026
Du Yafei, Wang Wenjing, Goh Hui Chin, Vaiyapuri Thamil Selvan, Raju Anandhkumar, Hsiao Yu-Chun, Wang Cheng Chun, Agrawal Vanisha, Mohideen Noorul Farzana, Mohd Mazian Norhidayah Binte, Karatekin Feride, Wang Wendy Kehan, Lakshmanan Manikandan, Gupta Komal, Chang Han, Le Guezennec Xavier, Bard Frederic, Tan Daniel S W, Tergaonkar Vinay, Hung Mien-Chie, Liu Xiaogang, Hong Wanjin, Boopathy Gandhi T K
Abstract excerpt
Activating mutations in the epidermal growth factor receptor (EGFR) gene drive non-small cell lung cancer (NSCLC). Oncogenic EGFR mutants are ligand-independent and more stable, but the underlying mechanism remains unclear. We hypothesized that EGFR mutants selectively leverage cellular stabilizers to evade degradation. Genome-wide RNA interference screens identified genes (encoding for stabilizers) responsible...
Topics
Join the communities discussing this publication.
